C.H. Robinson Worldwide, Inc. has taken a significant step in its growth strategy by amending its credit agreement to support the acquisition of RXO, Inc. This move is crucial as it allows the company to expand its operations in the freight and cargo transportation sector, a highly competitive industry.
On October 22, 2026, C.H. Robinson entered into a Fifth Amendment to its Credit Agreement, originally dated October 29, 2012. This amendment is designed to facilitate the previously announced acquisition of RXO, Inc., which is a strategic move that could enhance C.H. Robinson's market position.
Background
C.H. Robinson Worldwide, Inc. is a leading player in the arrangement of transportation of freight and cargo, classified under SIC 4731. The company is publicly traded on the Nasdaq under the ticker CHRW. Established in Delaware, C.H. Robinson has been a significant entity in the logistics and transportation industry, providing services that connect shippers with carriers.
What the Filing Says
The recent filing indicates that the Fifth Amendment allows the RXO acquisition to be classified as a "Permitted Acquisition" and a "Material Acquisition" under the Credit Agreement. It also revises the pro forma calculation of Consolidated EBITDA for Material Acquisitions, ensuring it reflects the historical financial statements of the acquired business. Additionally, the amendment maintains a maximum Net Leverage Ratio of 3.75 to 1.00 while eliminating the cap on cash netting.
Impact
This amendment is likely to affect various stakeholders, including the company's lenders and shareholders. By allowing for a Leverage Holiday upon completion of the RXO acquisition, the company is positioning itself to manage its financial obligations more flexibly during this transition. The freight and cargo transportation industry will also be closely monitoring how this acquisition impacts C.H. Robinson's competitive stance against other players in the market.
What's Next
The filing does not specify what happens next, but the successful completion of the RXO acquisition will likely lead to further strategic adjustments and operational integrations within C.H. Robinson. Stakeholders can expect additional updates as the company moves forward with this significant acquisition.
Read Next
AMETEK reports strong Q3 results, highlights growth in sector
AbbVie reports Q3 results, shows strong growth in pharma sector
Vista Credit Strategic Lending Corp. announces stock distribution
PAMT Corp Reports Q3 Loss Amid Industry Challenges
Palisades Venture reports Q3 2026 results, highlights growth
Metallus Inc. Reports Strong Q3 Results, Revenue Increases










